223 related articles for article (PubMed ID: 18426919)
1. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
[TBL] [Abstract][Full Text] [Related]
2. A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L.
Townsend HL; Jha BK; Silverman RH; Barton DJ
RNA Biol; 2008; 5(4):263-72. PubMed ID: 19088502
[TBL] [Abstract][Full Text] [Related]
3. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
4. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
Han JQ; Townsend HL; Jha BK; Paranjape JM; Silverman RH; Barton DJ
J Virol; 2007 Jun; 81(11):5561-72. PubMed ID: 17344297
[TBL] [Abstract][Full Text] [Related]
5. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
6. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
Williams GJ; De Benedetti A; Baglioni C
Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
[TBL] [Abstract][Full Text] [Related]
10. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
Nakanishi M; Goto Y; Kitade Y
Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
Yoshimura A; Nakanishi M; Yatome C; Kitade Y
J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
[TBL] [Abstract][Full Text] [Related]
12. A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.
Daou S; Talukdar M; Tang J; Dong B; Banerjee S; Li Y; Duffy NM; Ogunjimi AA; Gaughan C; Jha BK; Gish G; Tavernier N; Mao D; Weiss SR; Huang H; Silverman RH; Sicheri F
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24802-24812. PubMed ID: 32958664
[TBL] [Abstract][Full Text] [Related]
13. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
[TBL] [Abstract][Full Text] [Related]
14. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
15. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
16. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.
Park IH; Kwon YC; Ryu WS; Ahn BY
Antiviral Res; 2014 Apr; 104():118-27. PubMed ID: 24509240
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
[TBL] [Abstract][Full Text] [Related]
20. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
